GEMCITABINE, DEXAMETHASONE, AND CISPLATIN (GDP): EFFECTIVE AND WELL-TOLERATED SALVAGE THERAPY FOR RELAPSED/REFRACTORY HODGKIN LYMPHOMA (HL)

被引：0
|
作者：
Moccia, A. A. [1 ,2 ]
Hoskins, P. [1 ,2 ]
Klasa, R. [1 ,2 ]
Savage, K. J. [1 ,2 ]
Shenkier, T. [1 ,2 ]
Skinnider, B. [2 ,3 ]
Slack, G. [2 ,3 ]
Gascoyne, R. D. [2 ,3 ]
Connors, J. M. [1 ,2 ]
Sehn, L. H. [1 ,2 ]
机构：
[1] British Columbia Canc Agcy, Dept Med Oncol, Vancouver, BC, Canada
[2] Univ British Columbia, Vancouver, BC, Canada
[3] British Columbia Canc Agcy, Dept Pathol, Vancouver, BC, Canada
来源：
HAEMATOLOGICA | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P097
引用
收藏
页码：S28 / S29
页数：2
相关论文
共 50 条
  • [41] Gemcitabine, dexamethasone, high dose cytarabine and platinum (G-DHAP) is an effective salvage in relapsed and refractory lymphoma
    Rassam, M. B.
    Gupta, S.
    Thanigaikumar, M.
    Hill, M. E.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 526 - 526
  • [42] Salvage chemotherapy of gemcitabine, dexamethasone, and cisplatin (GDP) for patients with relapsed or refractory peripheral T-cell lymphomas: a consortium for improving survival of lymphoma (CISL) trial
    Park, Byeong-Bae
    Kim, Won Seog
    Suh, Cheolwon
    Shin, Dong-Yeop
    Kim, Jeong-A
    Kim, Hoon-Gu
    Lee, Won Sik
    [J]. ANNALS OF HEMATOLOGY, 2015, 94 (11) : 1845 - 1851
  • [43] Salvage chemotherapy of gemcitabine, dexamethasone, and cisplatin (GDP) for patients with relapsed or refractory peripheral T-cell lymphomas: a consortium for improving survival of lymphoma (CISL) trial
    Byeong-Bae Park
    Won Seog Kim
    Cheolwon Suh
    Dong-Yeop Shin
    Jeong-A Kim
    Hoon-Gu Kim
    Won Sik Lee
    [J]. Annals of Hematology, 2015, 94 : 1845 - 1851
  • [44] Gemcitabine and vinorelbine combination is effective in both as a salvage and mobilization regimen in relapsed or refractory Hodgkin lymphoma prior to ASCT
    Elif Suyanı
    Gülsan Türköz Sucak
    Şahika Zeynep Akı
    Zeynep Arzu Yeğin
    Zübeyde Nur Özkurt
    Münci Yağcı
    [J]. Annals of Hematology, 2011, 90 : 685 - 691
  • [45] Gemcitabine and vinorelbine combination is effective in both as a salvage and mobilization regimen in relapsed or refractory Hodgkin lymphoma prior to ASCT
    Suyani, Elif
    Sucak, Gulsan Turkoz
    Aki, Sahika Zeynep
    Yegin, Zeynep Arzu
    Ozkurt, Zubeyde Nur
    Yagci, Munci
    [J]. ANNALS OF HEMATOLOGY, 2011, 90 (06) : 685 - 691
  • [46] IGEV AN EFFECTIVE SALVAGE AND MOBILIZING REGIMEN IN REFRACTORY OR RELAPSED HODGKIN LYMPHOMA (HL): THE ISTITUTO NAZIONALE TUMORI EXPERIENCE
    Dalu, D.
    Viviani, S.
    Di Nicola, M.
    Carlo-Stella, C.
    Gianni, A. M.
    [J]. HAEMATOLOGICA, 2010, 95 : S31 - S31
  • [47] Gemcitabine, dexamethasone, cisplatin (GDP) salvage chemotherapy for relapsed or refractory Hodgkin's disease (HD): A National Cancer Institute of Canada Clinical Trials Group Study.
    Crump, M
    Baetz, T
    Belch, A
    Couban, S
    Meyer, R
    Imrie, K
    Yau, J
    Myers, R
    Paul, N
    Turner, R
    Shepherd, L
    Iglesias, J
    [J]. BLOOD, 2002, 100 (11) : 570A - 570A
  • [48] Cisplatin-based protocols as salvage therapy for relapsed or refractory Hodgkin's lymphoma patients.
    Alvarez, I
    Sureda, A
    Arranz, R
    Córdoba, R
    Xicoy, B
    Sánchez, B
    Bernal, MT
    Roncero, MIG
    Martí, E
    Pliego, A
    Fernández-Abellán, P
    Ribera, JM
    Fernández-Rañada, JM
    Sierra, J
    [J]. BLOOD, 2005, 106 (11) : 751A - 751A
  • [49] Weekly cisplatin with oral etoposide: a well-tolerated and highly effective regimen in relapsed ovarian cancer
    Verborg, W. A.
    Campbell, L. R.
    Highley, M. S.
    Rankin, E. M.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2008, 18 (02) : 228 - 234
  • [50] Bendamustine-bortezomib-dexamethasone is an active and well-tolerated regimen in patients with relapsed or refractory multiple myeloma
    Ludwig, Heinz
    Kasparu, Hedwig
    Leitgeb, Clemens
    Rauch, Elisabeth
    Linkesch, Werner
    Zojer, Niklas
    Greil, Richard
    Seebacher, Adelheid
    Pour, Ludek
    Weissmann, Adalbert
    Adam, Zdenek
    [J]. BLOOD, 2014, 123 (07) : 985 - 991
12345